ContentsSynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferencesView all Images (2)
Lead nephropathy
Other Resources UpToDate PubMed

Lead nephropathy

Contributors: Joon B. Kim MD, Carla Peracchia MD, Catherine Moore MD, Abhijeet Waghray MD
Other Resources UpToDate PubMed

Synopsis

Chronic lead exposure can lead to kidney damage. This typically occurs after prolonged high-level exposure (> 5-year duration and levels > 60 mcg/dL) and is more common in patients with an underlying risk for chronic kidney disease (eg, hypertension, diabetes mellitus).

Clinical manifestations are related to chronicity of exposure.
  • Acute exposure causes glucosuria, aminoaciduria, and renal phosphate wasting due to damage to the proximal tubules.
  • Chronic exposure causes an elevated serum creatinine and hyperuricemia without significant proteinuria.
Consider lead nephropathy in patients presenting with chronic kidney disease, hypertension, and gout who also have a past or present exposure to lead.

Primary treatment is elimination of further lead exposure. Chelation therapy can be considered, but studies of its effectiveness in treating lead nephropathy are not definitive.

Codes

ICD10CM:
N14.3 – Nephropathy induced by heavy metals

SNOMEDCT:
704204003 – Nephropathy induced by lead

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed:04/11/2019
Last Updated:04/11/2019
Copyright © 2022 VisualDx®. All rights reserved.
Lead nephropathy
Lead nephropathy (Acute Exposure) : Glycosuria
Copyright © 2022 VisualDx®. All rights reserved.